Skip to main content
. Author manuscript; available in PMC: 2024 Aug 1.
Published in final edited form as: Ann Thorac Surg. 2018 Dec 23;107(5):1494–1499. doi: 10.1016/j.athoracsur.2018.11.055

Table 4.

Smoking Cessation Practices Among Thoracic Surgeons Who Require Patients to Quit and Those Who Do Not

Surgeons Require Patients to Quit Smoking

Smoking Cessation Practices Yes No


n (%) n (%) p Value

Provide smoking cessation counseling 0.3
 Always 76 (95.0) 105 (87.5)
 Usually 2 (2.5) 8 (6.7)
 Sometimes 2 (2.5) 6 (5.0)
 Rarely 0 0
 Never 0 1 (0.8)
Refer patients to smoking cessation program 0.9
 Always 33 (41.3) 46 (38.3)
 Usually 17 (21.3) 26 (21.7)
 Sometimes 19 (23.8) 26 (21.7)
 Rarely 8 (10.0) 13 (10.8)
 Never 3 (3.8) 9 (7.5)
Prescribe nicotine replacement therapy 0.01
 Always 17 (21.3) 10 (8.3)
 Usually 24 (30.0) 26 (21.7)
 Sometimes 25 (31.3) 42 (35.0)
 Rarely 8 (10.0) 25 (20.8)
 Never 6 (7.5) 17 (14.2)
Prescribe medical therapya 0.02
 Always 7 (8.8) 4 (3.3)
 Usually 15 (18.8) 12 (10.0)
 Sometimes 33 (41.3) 39 (32.5)
 Rarely 13 (16.3) 36 (30.0)
 Never 12 (15.0) 29 (24.2)
a

Varenicline (Chantix; Pfizer Inc, Mission, KS) or bupropion (Wellbutrin; GlaxoSmithKline, Research Triangle Park, NC).